Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.
Gridelli C, Morabito A, Cavanna L, Luciani A, Maione P, Bonanno L, Filipazzi V, Leo S, Cinieri S, Ciardiello F, Burgio MA, Bilancia D, Cortinovis D, Rosetti F, Bianco R, Gebbia V, Artioli F, Bordonaro R, Fregoni V, Mencoboni M, Nelli F, Riccardi F, di Isernia G, Costanzo R, Rocco G, Daniele G, Signoriello S, Piccirillo MC, Gallo C, Perrone F. Gridelli C, et al. Among authors: nelli f. J Clin Oncol. 2018 Sep 1;36(25):2585-2592. doi: 10.1200/JCO.2017.76.8390. Epub 2018 Jul 20. J Clin Oncol. 2018. PMID: 30028656 Clinical Trial.
Quality of life in lung cancer patients.
Gridelli C, Perrone F, Nelli F, Ramponi S, De Marinis F. Gridelli C, et al. Among authors: nelli f. Ann Oncol. 2001;12 Suppl 3:S21-5. doi: 10.1093/annonc/12.suppl_3.s21. Ann Oncol. 2001. PMID: 11804379 Free article.
Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.
Cappuzzo F, De Marinis F, Nelli F, Calandri C, Maestri A, Benedetti G, Migliorino MR, Cortesi E, Rastelli F, Martelli O, Andruccetti M, Bartolini S, Crinò L. Cappuzzo F, et al. Among authors: nelli f. Lung Cancer. 2003 Dec;42(3):355-61. doi: 10.1016/s0169-5002(03)00365-9. Lung Cancer. 2003. PMID: 14644524 Clinical Trial.
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma.
De Marinis F, Nelli F, Lombardo M, Ferraú F, Barbera S, Bertetto O, Barni S, Michetti G, Labianca R, Gridelli C. De Marinis F, et al. Among authors: nelli f. Cancer. 2005 Feb 15;103(4):772-9. doi: 10.1002/cncr.20859. Cancer. 2005. PMID: 15641037 Free article. Clinical Trial.
Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer.
Trodella L, De Marinis F, D'Angelillo RM, Ramella S, Cesario A, Valente S, Nelli F, Migliorino MR, Margaritora S, Corbo GM, Porziella V, Ciresa M, Cellini F, Bonassi S, Russo P, Cortesi E, Granone P. Trodella L, et al. Among authors: nelli f. Lung Cancer. 2006 Dec;54(3):331-8. doi: 10.1016/j.lungcan.2006.07.020. Epub 2006 Sep 29. Lung Cancer. 2006. PMID: 17011065 Clinical Trial.
76 results